RMR Advisors LLC trimmed its holdings in National Health Investors Inc (NYSE:NHI) by 12.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 56,893 shares of the real estate investment trust’s stock after selling 7,816 shares during the quarter. National Health Investors makes up about 1.6% of RMR Advisors LLC’s holdings, making the stock its 17th biggest position. RMR Advisors LLC owned 0.13% of National Health Investors worth $4,469,000 as of its most recent SEC filing.
Several other institutional investors have also made changes to their positions in the company. Pensionfund Sabic increased its holdings in shares of National Health Investors by 280.0% in the 1st quarter. Pensionfund Sabic now owns 9,500 shares of the real estate investment trust’s stock valued at $746,000 after acquiring an additional 7,000 shares during the period. Pensionfund DSM Netherlands increased its holdings in shares of National Health Investors by 266.7% in the 1st quarter. Pensionfund DSM Netherlands now owns 22,000 shares of the real estate investment trust’s stock valued at $1,728,000 after acquiring an additional 16,000 shares during the period. Deutsche Bank AG increased its stake in National Health Investors by 62.5% in the 4th quarter. Deutsche Bank AG now owns 207,051 shares of the real estate investment trust’s stock valued at $15,636,000 after buying an additional 79,647 shares during the period. Liberty Wealth Management LLC acquired a new position in National Health Investors in the 4th quarter valued at $69,000. Finally, American Century Companies Inc. increased its stake in National Health Investors by 99.8% in the 4th quarter. American Century Companies Inc. now owns 149,363 shares of the real estate investment trust’s stock valued at $11,283,000 after buying an additional 74,604 shares during the period. 71.17% of the stock is currently owned by institutional investors and hedge funds.
Shares of NYSE:NHI traded down $1.14 on Wednesday, reaching $75.11. 49,536 shares of the company were exchanged, compared to its average volume of 202,938. The company has a quick ratio of 17.92, a current ratio of 17.92 and a debt-to-equity ratio of 0.92. National Health Investors Inc has a 1-year low of $65.10 and a 1-year high of $84.57. The stock has a market cap of $3.26 billion, a PE ratio of 13.71, a price-to-earnings-growth ratio of 3.54 and a beta of 0.51.
The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Friday, March 29th will be paid a dividend of $1.05 per share. The ex-dividend date is Thursday, March 28th. This is a boost from National Health Investors’s previous quarterly dividend of $1.00. This represents a $4.20 dividend on an annualized basis and a dividend yield of 5.59%. National Health Investors’s dividend payout ratio is 76.64%.
In other news, Director Robert A. Mccabe, Jr. sold 1,181 shares of the company’s stock in a transaction on Thursday, February 21st. The shares were sold at an average price of $78.04, for a total transaction of $92,165.24. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 5.11% of the company’s stock.
Several equities analysts have issued reports on NHI shares. BMO Capital Markets cut shares of National Health Investors from a “market perform” rating to an “underperform” rating and set a $78.00 price objective on the stock. in a research note on Wednesday, February 20th. KeyCorp set a $65.00 price objective on shares of National Health Investors and gave the company a “sell” rating in a research note on Thursday, December 20th. ValuEngine cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Monday, April 1st. SunTrust Banks boosted their price objective on shares of National Health Investors to $85.00 and gave the company a “neutral” rating in a research note on Wednesday, February 20th. They noted that the move was a valuation call. Finally, Zacks Investment Research raised shares of National Health Investors from a “sell” rating to a “hold” rating in a research note on Tuesday, February 12th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $78.14.
WARNING: This piece was originally published by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The correct version of this piece can be read at https://www.baseballdailydigest.com/news/2019/04/17/rmr-advisors-llc-sells-7816-shares-of-national-health-investors-inc-nhi.html.
National Health Investors Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Featured Story: Options Trading – What is a Straddle?
Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors Inc (NYSE:NHI).
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.